EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Advanced Solid Tumor · Homologous Recombination Deficiency · HRR Deficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Study leads
Timothy Yap
Principal Investigator
M.D. Anderson Cancer Center